SNSE/TMOCL (SNSE/TMOCL)

Santiago Stock Exchange: SNSE/TMOCL · CLP

CLP 680,980

+13920.01 (+2.1%)· Recorded snapshot

Market cap	251.7T
Revenue (ttm)	45.8T
Net income (ttm)	6.8T
EPS (ttm)	CLP 18,747
P/E (trailing)	36.3x
P/E (forward)	25.7x
Dividend	CLP 1,697 (0.25%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 45.8T
Net income (ttm): 6.8T
EPS (ttm): CLP 18,747
P/E (trailing): 36.3x
P/E (forward): 25.7x
Market cap: 251.7T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E25.7

P25 n/aP50 n/aP75 n/a

Trailing P/E36.3

P25 n/aP50 n/aP75 n/a

ROE13.4

P25 n/aP50 n/aP75 n/a

ROIC9.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SNSE/TMOCL indicators

Market & fundamental data

Available fields

212

Groups with data

Currency

USD

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CLP
Country	United States
Country code	CL
Earnings date	2026-10-21
Employees	125,000
Employees change	0
Employees growth	0%
Enterprise value	CLP 286.5T
Exchange	Santiago Stock Exchange
Financial currency	USD
Financial report date	2026-09-26
First seen	2026-07-12
Fiscal year end	December
Founded	1956
Industry	Diagnostics & Research
Is primary listing	No
ISIN number	US8835561023
Last earnings date	2026-10-21
Last refreshed	2026-10-28
Market cap	CLP 251.7T
Price	CLP 680,980.00
Price currency	CLP
Sector	Healthcare
SIC code	3826
Stock price date	2026-10-27
Symbol	snse/TMOCL
Website	https://www.thermofisher.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	31.57x
Average P/E ratio (3Y)	31.2x
Average P/E ratio (5Y)	31.63x
Earnings yield	2.75%
EV/Earnings	41.83x
EV/EBIT	32.31x
EV/EBITDA	23.09x
EV/FCF	38.95x
EV/Sales	6.16x
FCF / EV yield	2.57%
FCF yield	2.92%
Forward P/E	25.66x
Graham number	244874.84179
Graham upside	-64.04%
Lynch fair value	CLP 92,646.21
Lynch upside	-86.4%
P/(FCF - SBC) ratio	35.67x
P/(OCF - SBC) ratio	28.83x
P/B ratio	4.73x
P/E ratio	36.33x
P/FCF ratio	34.22x
P/OCF ratio	27.88x
P/S ratio	5.49x
Price/EBITDA ratio	21.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	19.2%
EBITDA margin	25.76%
Effective tax rate	9.48%
FCF margin	15.72%
Gross margin	41.18%
Operating margin	19.2%
Pretax margin	16.55%
Profit margin	14.94%
Profit per employee	CLP 54.8M
Profitable quarters	98
Profitable years	24
Revenue per employee	CLP 366.8M
ROA	5.23%
ROA (5Y)	5.62%
ROCE	9.09%
ROE	13.38%
ROE (5Y)	15.21%
ROIC	9.07%
ROIC (5Y)	10.84%
SBC / revenue	0.65%
Tax / revenue	1.57%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	9.54%
EPS growth (Q)	8.67%
EPS growth (QoQ)	-0.84%
EPS growth 10Y	14.26%
EPS growth 3Y	7.53%
EPS growth 5Y	-2.52%
EPS growth quarters	7
EPS growth years	2
FCF growth	24.3%
FCF growth (Q)	15.15%
FCF growth (QoQ)	26.15%
FCF growth 3Y	5.08%
FCF growth 5Y	-0.82%
Gross profit growth	7.71%
Gross profit growth (Q)	13.24%
Gross profit growth 3Y	3.89%
Gross profit growth 5Y	-0.46%
Net income growth	7.64%
Net income growth (Q)	6.5%
Net income growth (QoQ)	-0.86%
Net income growth 3Y	5.98%
Net income growth 5Y	-3.76%
Net income growth quarters	3
Net income growth years	2
OCF growth	21.87%
OCF growth (Q)	13.89%
OCF growth (QoQ)	20%
OCF growth 10Y	11.01%
OCF growth 3Y	4.5%
OCF growth 5Y	-1.77%
Operating income growth	11.07%
Operating income growth (Q)	14.32%
Operating income growth 3Y	6.53%
Operating income growth 5Y	-3.21%
Revenue growth	8.27%
Revenue growth (Q)	9.13%
Revenue growth (QoQ)	1.19%
Revenue growth 10Y	10.17%
Revenue growth 3Y	2.93%
Revenue growth 5Y	3.93%
Revenue growth quarters	8
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CLP -1.7T
Depreciation and amortization	CLP 3.1T
EBIT	CLP 8.8T
EBITDA	CLP 11.8T
EPS	CLP 18,746.77
Financing cash flow	CLP 1.9T
Free cash flow	CLP 7.4T
Free cash flow minus SBC	CLP 7.1T
Gross profit	CLP 18.9T
Income taxes	CLP 719.4B
Investing cash flow	CLP -7.7T
Net borrowing	CLP 6.3T
Net cash flow	CLP 3.4T
Net income	CLP 6.8T
Operating cash flow minus SBC	CLP 8.7T
Operating income	CLP 8.8T
Revenue	CLP 45.8T
Stock-based compensation	CLP 300.2B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CLP 143,319.32
Debt / EBITDA	3.26
Debt / equity	0.75
Debt / FCF	5.45
Goodwill	CLP 53.6T
Interest coverage	5.92
Long-term assets	CLP 85.3T
Long-term liabilities	CLP 43.4T
Net cash (debt)	CLP -34.2T
Net cash / market cap	-13.59%
Net debt / EBITDA	2.89
Net debt / equity	0.64
Net debt / FCF	4.65
Piotroski F-Score	6
Property, plant and equipment	CLP 10.5T
Shareholders' equity	CLP 53.2T
Tangible book value	CLP -17T
Tangible book value per share	CLP -45,986.64
Total assets	CLP 110.6T
Total cash	CLP 5.9T
Total debt	CLP 40.1T
Total liabilities	CLP 57.5T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.44
Current assets	CLP 25.3T
Current liabilities	CLP 14T
Current ratio	1.81
Inventory turnover	4.89
Net working capital	CLP 7.4T
Quick ratio	1.11
Working capital	CLP 11.1T
Working capital turnover	4,863.95

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.52%
Dividend growth	6.24%
Dividend growth years	2
Dividend payment date	2026-10-15
Dividend payment years	4
Dividend payout frequency	Quarterly
Dividend per share	CLP 1,696.57
Dividend yield	0.25%
Ex-dividend date	2026-09-15
Last dividend	CLP 450.47
Payout ratio	9.52%
Shareholder yield	1.77%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	2.09%
1M price change	8.59%
1M total return	8.59%
1W price change	4.72%
1W total return	4.72%
20-day SMA	CLP 660,724.00
3M price change	38.7%
3M total return	38.81%
50-day SMA	CLP 609,872.80
52-week high	CLP 680,980.00
52-week high date	2026-10-27
52-week low	CLP 414,990.00
52-week low date	2026-06-23
All-time high	CLP 680,980.00
All-time high date	2026-10-27
All-time low	CLP 414,990.00
All-time low date	2026-05-08
Average true range (ATR)	CLP 3,893.39
Average volume	0
Change from 52-week high	0%
Change from 52-week low	64.1%
Change from all-time high	0%
Change from all-time low	64.1%
Monthly RSI	0
Previous close	CLP 667,060.00
Price vs 20-day SMA	3.07%
Price vs 50-day SMA	11.66%
RSI	86.33
Sharpe ratio	3.76
Sortino ratio	18.94
Weekly RSI	87.95

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	368.8M
Shares change (QoQ)	0%
Shares change (YoY)	-1.52%
Shares held by insiders	0.12%
Shares held by institutions	92.52%
Short ratio	2.3 days

Deeper analysis on SNSE/TMOCL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SNSE/TMOCL report

Is a complete SNSE/TMOCL research report available?

No complete published report is available for snse/TMOCL (SNSE/TMOCL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SNSE/TMOCL (SNSE/TMOCL)

Price

Financial snapshot

Fair-value bridge

Latest news · SNSE/TMOCL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SNSE/TMOCL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SNSE/TMOCL

Frequently asked questions